4:28 PM
 | 
Jul 14, 2014
 |  BC Extra  |  Politics & Policy

India caps prices of 50 CV and diabetes drugs

India's National Pharmaceutical Pricing Authority ( NPPA) Januvia sitagliptin from Merck & Co. Inc. (NYSE:MRK) and Volibo voglibose from Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA). The only non-insulin diabetes drugs included on India's list of essential medicines are...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >